The Sanofi-Pasteur vaccines arm will gain a majority stake in Hyderabad-based Shantha Biotechnics by buying ShanH, a subsidiary of French healthcare-products group Merieux Alliance. The deal, expected to close by the end of the third quarter, will assist Sanofi"s expansion into India as well as being able to access Shantha"s new product pipeline including an experimental typhoid vaccine.
저작권자 © 메디칼업저버 무단전재 및 재배포 금지